Cargando…

External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality

Assessing prevalent comorbidities is a common approach in health research for identifying clinical differences between individuals. The objective of this study was to validate and compare the predictive performance of two variants of the Elixhauser comorbidity measures (ECM) for inhospital mortality...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fortin, Yannick, Crispo, James A. G., Cohen, Deborah, McNair, Douglas S., Mattison, Donald R., Krewski, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369776/ https://www.ncbi.nlm.nih.gov/pubmed/28350807 http://dx.doi.org/10.1371/journal.pone.0174379

Ejemplares similares

Systemic quinolones and risk of acute liver failure III: A nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2021)

Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2022)

The Deyo-Charlson and Elixhauser-van Walraven Comorbidity Indices as predictors of mortality in critically ill patients
por: Ladha, Karim S, et al.
Publicado: (2015)

The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
por: Bonnesen, Kasper, et al.
Publicado: (2023)

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease
por: Crispo, James A. G., et al.
Publicado: (2016)

National Norms for the Elixhauser and Charlson Comorbidity Indexes Among Hospitalized Adults
por: Loyd, Christine, et al.
Publicado: (2021)

Comparing the Performance of Charlson and Elixhauser Comorbidity Indices to Predict In-Hospital Mortality Among a Chinese Population
por: Cai, Miao, et al.
Publicado: (2020)

Performance of Charlson and Elixhauser Comorbidity Index to Predict in-Hospital Mortality in Patients with Stroke in Sumadija and Western Serbia
por: Bajic, Biljana, et al.
Publicado: (2021)

Homogeneous Group approach to Elixhauser comorbidity for hospital death using administrative data
por: Chlebicki, Andrzej Z., et al.
Publicado: (2019)

Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
por: Snow, Gregory L., et al.
Publicado: (2020)

Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data
por: Sharma, Narayan, et al.
Publicado: (2021)

Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study
por: Farhat, Nawal, et al.
Publicado: (2020)

Toolkit to Compute Time-Based Elixhauser Comorbidity Indices and Extension to Common Data Models
por: Syed, Shorabuddin, et al.
Publicado: (2020)

Prognosis models for severe and critical COVID-19 based on the Charlson and Elixhauser comorbidity indices
por: Zhou, Wei, et al.
Publicado: (2020)

Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices
por: Prommik, Pärt, et al.
Publicado: (2022)

Off-label use of cancer therapies in women diagnosed with breast cancer in the United States
por: Hamel, Sophie, et al.
Publicado: (2015)

Validation and Comparison of a Modified Elixhauser Index for Predicting In-Hospital Mortality in Italian Internal Medicine Wards
por: De Giorgi, Alfredo, et al.
Publicado: (2020)

Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the charlson and elixhauser comorbidity measures in predicting mortality
por: Li, Pengxiang, et al.
Publicado: (2010)

Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases
por: Li, Bing, et al.
Publicado: (2008)

Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices
por: Buhr, Russell G., et al.
Publicado: (2019)

Comparison of Elixhauser and Charlson Methods for Discriminative Performance in Mortality Risk in Patients with Schizophrenic Disorders
por: Tsai, Kuan-Yi, et al.
Publicado: (2020)

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

Discriminative Ability for Adverse Outcomes in Traumatic Ankle Fracture: A Comparison of the Modified Charlson Comorbidity Index, Elixhauser Comorbidity Measure, and Modified Frailty Index
por: Mehta, Sanket, et al.
Publicado: (2022)

The Effectiveness of National Early Warning Score, Quick Sequential Organ Failure Assessment, Charlson Comorbidity Index, and Elixhauser Comorbidity Index Scores in Predicting Mortality Due to COVID-19 in Elderly Patients
por: Akman, Canan, et al.
Publicado: (2022)

Association between medication-related adverse events and non-elective readmission in acute ischemic stroke
por: Crispo, James A. G., et al.
Publicado: (2018)

Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival
por: Chang, Heng-Jui, et al.
Publicado: (2016)

Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018
por: Vesterager, Jeppe Damgren, et al.
Publicado: (2022)

Racial disparities in COVID-19 outcomes exist despite comparable Elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites
por: Qeadan, Fares, et al.
Publicado: (2021)

Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases
por: Metcalfe, David, et al.
Publicado: (2019)

Elixhauser comorbidity measures-based risk factors associated with 30-day mortality in elderly population after femur fracture surgery: a propensity score-matched retrospective case-control study
por: Kim, Dohyung, et al.
Publicado: (2020)

Association of treatments for acute appendicitis with pregnancy outcomes in the United States from 2000 to 2016: Results from a multi-level analysis
por: Yang, Jianzhou, et al.
Publicado: (2021)

Validation of an obstetric comorbidity index in an external population
por: Metcalfe, A, et al.
Publicado: (2015)

A Comparison of the Charlson and Elixhauser Methods for Predicting Nursing Indicators in Gastrectomy with Gastric Cancer Patients
por: Kim, Chul-Gyu, et al.
Publicado: (2023)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
por: Alami, Abdallah, et al.
Publicado: (2022)

Impact of Retinopathy and Systemic Vascular Comorbidities on All-Cause Mortality
por: Zhu, Zhuoting, et al.
Publicado: (2021)

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
por: Alami, Abdallah, et al.
Publicado: (2023)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
por: Alami, Abdallah, et al.
Publicado: (2023)

Association of BMI, comorbidities and all-cause mortality by using a baseline mortality risk model
por: Li, Jia, et al.
Publicado: (2021)

Improving the external validity of clinical trials: the case of multiple chronic conditions
por: Martin, Fortin, et al.
Publicado: (2013)

Development and validation of prediction model to estimate 10-year risk of all-cause mortality using modern statistical learning methods: a large population-based cohort study and external validation
por: Ajnakina, Olesya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bjn5fi6q4efgf0hf19f6k1g2ka